3 ms·
Pharma benefits - not just from vaccine profits, but from the new drug they’re currently testing, molnupiravir. Unlike IVM, it’s patentable, though it operates
by mmmeff 5y ago
Pharma benefits - not just from vaccine profits, but from the new drug they’re currently testing, molnupiravir. Unlike IVM, it’s patentable, though it operates on a similar biomechanism as IVM (protease inhibition). Merck plans to charge thousands per dose once they wrap clinical trials. Fauci is on the record hyping this new drug as well.
- oblio 5y agoAnd this is a worldwide conspiracy where they're able to buy all the medical bodies across the world, including in countries with conflicting interests, plus the all the world's top physicians? I don't buy it.